3.2 Electrolyte Disorders in the ICU

Electrolyte Disorders in the ICU

Electrolyte abnormalities are ubiquitous in the intensive care unit, arising from underlying disease processes, organ dysfunction, and iatrogenic interventions (e.g., medications, fluid therapy). Prompt recognition and appropriate management of these disorders are critical, as severe derangements can lead to life-threatening arrhythmias, neurologic catastrophes, and death. The BCCCP must expertly navigate the complexities of replacing, shifting, or removing electrolytes.

Sodium Disorders: Hyponatremia

Hyponatremia (serum sodium < 135 mEq/L) is primarily a disorder of water balance, not necessarily a sodium deficit. It is the most common electrolyte abnormality in hospitalized patients. The diagnostic approach begins with assessing serum osmolality to confirm true (hypotonic) hyponatremia, followed by an assessment of the patient's volume status (hypovolemic, euvolemic, or hypervolemic).

Management of Severe Symptomatic Hyponatremia

When a patient presents with severe hyponatremia (typically < 120 mEq/L) accompanied by severe neurologic symptoms (seizures, coma, severe altered mental status), this represents acute cerebral edema and constitutes a medical emergency. The treatment of choice is 3% hypertonic saline.

• Goal: The immediate goal is to rapidly increase the serum sodium by 4 to 6 mEq/L over the first few hours. This small increase is usually sufficient to reverse life-threatening cerebral edema and arrest seizures.
• Dosing: A common approach is to administer 3% saline as a 100-150 mL bolus over 10-20 minutes, which can be repeated up to two times if severe symptoms persist.
• The Risk of Overcorrection: While rapid initial correction is necessary for acute symptoms, correcting sodium too quickly overall poses a severe risk of Osmotic Demyelination Syndrome (ODS) (formerly central pontine myelinolysis). ODS causes irreversible neurologic damage (paralysis, dysphagia, "locked-in" syndrome). To prevent ODS, the total correction of serum sodium must not exceed 8 mEq/L in any 24-hour period (and no more than 18 mEq/L in 48 hours) for patients with chronic hyponatremia or hyponatremia of unknown duration.

Potassium Disorders

Potassium is the primary intracellular cation. Even small changes in the extracellular potassium concentration can have profound effects on the resting membrane potential of cardiac and neuromuscular cells.

Hyperkalemia

Hyperkalemia (serum potassium > 5.0 mEq/L) is common in the ICU, often resulting from acute kidney injury (AKI), medications (ACE inhibitors, ARBs, potassium-sparing diuretics), rhabdomyolysis, or metabolic acidosis (which causes extracellular potassium shift). Severe hyperkalemia (> 6.5 mEq/L) or hyperkalemia with EKG changes (peaked T waves, widened QRS, loss of P wave, sine wave) requires immediate intervention using a three-pronged approach:

1. Membrane Stabilization:

   • Agent: Intravenous Calcium (Calcium Gluconate or Calcium Chloride).
   • Mechanism: Calcium antagonizes the membrane actions of hyperkalemia, raising the threshold potential and stabilizing the myocardium, thereby preventing lethal arrhythmias. It does not lower the serum potassium level.
   • Note: Calcium chloride provides three times more elemental calcium per 10 mL ampule than calcium gluconate but requires central venous access due to the risk of severe tissue necrosis with extravasation. Calcium gluconate is preferred for peripheral administration.

2. Intracellular Shifting:

   • Agents: Regular Insulin (with Dextrose to prevent hypoglycemia), Albuterol (high-dose nebulized), Sodium Bicarbonate (primarily effective if concurrent metabolic acidosis is present).
   • Mechanism: These agents drive potassium from the extracellular space into the intracellular space. The effect is rapid (onset 15-30 mins) but temporary (duration 2-6 hours).

3. Elimination:

   • Agents: Loop diuretics (e.g., furosemide, if the patient makes urine), Gastrointestinal cation-exchange resins/binders (e.g., sodium polystyrene sulfonate, patiromer, sodium zirconium cyclosilicate), or Hemodialysis.
   • Mechanism: These are the only methods that actually remove potassium from the body. Hemodialysis is the most rapid and effective method, indicated for severe, refractory hyperkalemia or when significant AKI/anuria is present.

Hypokalemia

Hypokalemia (serum potassium < 3.5 mEq/L) can cause muscle weakness, respiratory failure, and dangerous arrhythmias (e.g., Torsades de Pointes). Treatment involves oral or intravenous potassium replacement. A critical concept in managing hypokalemia is the role of magnesium.

Magnesium Disorders

Magnesium is the second most abundant intracellular cation and acts as a crucial cofactor in over 300 enzymatic reactions, including those involving ATP and the Na+/K+ ATPase pump.

Hypomagnesemia and Refractory Hypokalemia

Hypomagnesemia (serum magnesium < 1.5 mg/dL) frequently coexists with hypokalemia. Importantly, hypokalemia is often refractory to potassium replacement if concurrent hypomagnesemia is not corrected first.

• Mechanism: Magnesium is required for the proper function of the Na+/K+ ATPase pump, which maintains intracellular potassium. Furthermore, low intracellular magnesium in the distal renal tubule removes the inhibitory check on the ROMK (Renal Outer Medullary Potassium) channel, leading to excessive renal potassium wasting. Until magnesium is repleted, administered potassium will continue to be lost in the urine.
• Management: Always check a magnesium level in patients with hypokalemia. Intravenous magnesium sulfate (typically 1-4 grams depending on severity) is the treatment of choice for significant hypomagnesemia in the ICU.

Clinical Scenario

A 58-year-old female with chronic kidney disease (baseline creatinine 1.8 mg/dL) is admitted to the ICU with profound weakness. Her medications include lisinopril and spironolactone. Her lab results reveal a serum potassium of 7.2 mEq/L and a creatinine of 3.4 mg/dL. Her EKG shows significantly widened QRS complexes and peaked T waves.

This patient has life-threatening hyperkalemia with EKG changes. The immediate priority is myocardial stabilization to prevent ventricular fibrillation. She should immediately receive IV calcium (gluconate peripherally or chloride centrally). Following calcium, she requires therapies to shift potassium intracellularly (10 units of IV regular insulin administered with 50 mL of 50% dextrose). Finally, because she has acute kidney injury on top of chronic kidney disease and is likely oliguric, she will likely require urgent hemodialysis to definitively remove potassium from her body, though loop diuretics and GI binders can be attempted if dialysis is delayed.